NCT01030731View on ClinicalTrials.gov

Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Staphylococcal Skin InfectionsStreptococcal Infections
Interventions
DRUG

Ceftobiprole

Ceftobiprole 250mg single dose over 2 hours.

Sponsors
All Listed Sponsors
collaborator

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

lead

Basilea Pharmaceutica

INDUSTRY